OrthoPediatrics Corp. (NASDAQ:KIDS) Receives Consensus Rating of "Moderate Buy" from Brokerages

Key Points

• OrthoPediatrics Corp. has received a consensus recommendation of "Moderate Buy" from analysts, with eight current analysts covering the company, including seven buy recommendations.
• Recent price targets for OrthoPediatrics stock range from $35.00 by JMP Securities to $39.00 by BTIG Research, indicating a positive outlook despite a recent stock decline of 2.0%.
• Insider trading activity includes CFO Fred Hite purchasing 5,076 shares at an average price of $19.41, increasing his ownership stake in the company.

OrthoPediatrics Corp. (NASDAQ:KIDS - Get Free Report) has been given an average recommendation of "Moderate Buy" by the eight analysts that are presently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a hold rating and seven have given a buy rating to the company. The average 12-month price objective among brokers that have updated their coverage on the stock in the last year is $34.1429.

A number of analysts have recently commented on the company. JMP Securities set a $35.00 price objective on OrthoPediatrics and gave the stock a "market outperform" rating in a report on Friday, August 8th. Citigroup restated a "market outperform" rating on shares of OrthoPediatrics in a report on Friday, August 8th. BTIG Research dropped their price objective on OrthoPediatrics from $40.00 to $39.00 and set a "buy" rating for the company in a report on Wednesday, August 6th. Finally, Wall Street Zen upgraded OrthoPediatrics from a "sell" rating to a "hold" rating in a report on Saturday, August 9th.

Insiders Place Their Bets

In other OrthoPediatrics news, CFO Fred Hite purchased 5,076 shares of the firm's stock in a transaction that occurred on Thursday, August 21st. The stock was purchased at an average cost of $19.41 per share, with a total value of $98,525.16. Following the transaction, the chief financial officer owned 213,065 shares in the company, valued at approximately $4,135,591.65. This trade represents a 2.44% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 32.70% of the company's stock.

Institutional Trading of OrthoPediatrics

Institutional investors have recently added to or reduced their stakes in the business. Millennium Management LLC purchased a new position in OrthoPediatrics in the 4th quarter valued at about $9,798,000. Point72 Asset Management L.P. bought a new position in OrthoPediatrics in the fourth quarter worth about $7,450,000. Harbor Capital Advisors Inc. lifted its holdings in OrthoPediatrics by 116.5% in the second quarter. Harbor Capital Advisors Inc. now owns 333,959 shares of the company's stock worth $7,173,000 after acquiring an additional 179,733 shares during the last quarter. Wellington Management Group LLP lifted its holdings in OrthoPediatrics by 20.2% in the fourth quarter. Wellington Management Group LLP now owns 1,061,299 shares of the company's stock worth $24,601,000 after acquiring an additional 178,078 shares during the last quarter. Finally, Paradigm Capital Management Inc. NY lifted its holdings in OrthoPediatrics by 1,607.0% in the first quarter. Paradigm Capital Management Inc. NY now owns 170,700 shares of the company's stock worth $4,204,000 after acquiring an additional 160,700 shares during the last quarter. 69.05% of the stock is owned by hedge funds and other institutional investors.

OrthoPediatrics Price Performance

Shares of KIDS traded down $0.68 during mid-day trading on Wednesday, reaching $19.65. 201,048 shares of the company's stock were exchanged, compared to its average volume of 127,761. The company has a market cap of $492.63 million, a price-to-earnings ratio of -10.98 and a beta of 1.06. The company has a quick ratio of 3.43, a current ratio of 6.66 and a debt-to-equity ratio of 0.27. OrthoPediatrics has a 52-week low of $16.59 and a 52-week high of $33.14. The company has a 50-day simple moving average of $20.90 and a two-hundred day simple moving average of $21.88.

OrthoPediatrics (NASDAQ:KIDS - Get Free Report) last released its earnings results on Tuesday, August 5th. The company reported ($0.11) EPS for the quarter, topping the consensus estimate of ($0.17) by $0.06. The firm had revenue of $61.08 million during the quarter, compared to analysts' expectations of $61.40 million. OrthoPediatrics had a negative net margin of 18.92% and a negative return on equity of 6.36%. OrthoPediatrics has set its FY 2025 guidance at EPS. On average, sell-side analysts predict that OrthoPediatrics will post -0.93 EPS for the current fiscal year.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.